Korean stem cell firm to expand in US merger
This article was originally published in Clinica
Executive Summary
Korean stem cell research and therapy firm Histostem (Seoul) is set to expand into the US market. A memorandum of understanding signed with Florida-based Stem Cell Therapy International to merge the two companies will become a definitive agreement once operational details have been worked out.